Kano Therapeutics

Kano Therapeutics is a biotechnology company developing a new class of biomolecules for gene insertions using single-stranded DNA (ssDNA). Their platform offers a safer, more efficient, and scalable alternative to existing gene editing methods, enabling the creation of therapies for complex genetic diseases. The company aims to bridge the gap between gene editing and gene replacement.

Buy Funded Startups lists

Funding Round: Seed

Funding Amount: $7.1M

Date: 12-Aug-2024

Investors: The Engine Ventures, VSquared Ventures, Taihill Venture, Metaplanet

Markets: Biotechnology, Genetic Medicine, Gene Therapy, DNA therapeutics, CRISPR, Biological engineering

HQ: Cambridge, Massachusetts, United States

Founded: 2021

Website: https://kanotherapeutics.com/

LinkedIn: https://www.linkedin.com/company/kano-therapeutics/

Twitter: https://twitter.com/kano_tx

Instagram: